US 9708392
Monoclonal antibodies against orthopoxviruses
granted A61KA61K2039/505A61K2039/545
Quick answer
US patent 9708392 (Monoclonal antibodies against orthopoxviruses) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jul 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K2039/505, A61K2039/545, A61K39/00, A61P